drugset / Trial / NCT00003035
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different ways may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of doxorubicin with paclitaxel in treating women who have locally advanced breast cancer.
Timeline
- Start
- 1997-03
- Primary completion
- 2001-06
- Completion
- 2001-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | Other |
| Subject | Paclitaxel | Small molecule | — | Intravenous |
| Background | Tamoxifen | Small molecule | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | Subcutaneous |